DANAHER CORPORATION

Lobbying for DANAHER CORPORATION · health care products developer and manufacturer

Filing 3rd Quarter - Report

3rd Quarter (July 1 - Sep 30) 2025 · District of Columbia · House · Senate · $270,000.00 expenses · posted Oct 20, 2025

Lobbying activity 3

Health Issues

Issues related to genomic medicines Issues related to biotechnology, cell and gene therapy

Tariff (miscellaneous tariff bills)

General issues related to tariffs

Trade (domestic/foreign)

Discussions regarding export controls

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.